CLOV
Get informed when a big investor buys or sells
+ FollowOvervalued by 179.8% based on the discounted cash flow analysis.
| Market cap | $2.16 Billion |
|---|---|
| Enterprise Value | $1.99 Billion |
| Dividend Yield | $0.10 (-) |
| Earnings per Share | $-0.17 |
| Beta | 2.42 |
| Outstanding Shares | 522,184,385 |
| P/E Ratio | -37.47 |
|---|---|
| PEG | 1.67 |
| Price to Sales | 1.07 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.9 |
| Enterprise Value to EBIT | -34.91 |
| Enterprise Value to Net Income | -35 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 57.87% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.39%▼ 24.02% |
|---|---|
| Total Invested | $10.71M▼ 95.23% |
| Investors Holding | 51▼ 168.00% |
No data
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outco...